Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2012 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (214)	4/13/2012 5:48:46 PM
From: Arthur Radley	Respond to of 513

All the work and NOW some fun! Congratulations on your stellar performance...........'you be the man'!

To: BulbaMan who wrote (214)	4/13/2012 6:11:36 PM
From: pgo-neil	Read Replies (2) \| Respond to of 513

Congrats to Bulba on moving into first place. Two stocks in the top 5 this week looked good [AMF.TO and IDRA]. And I see that this is the week I slid off the top ten list. Sic transit Gloria... [Uhh, what was Gloria's last name again?] All the best, graham --

To: BulbaMan who wrote (214)	4/15/2012 2:43:11 PM
From: scaram(o)uche	Respond to of 513

>> BULBA 45,170 << A pause for our "feel good" moment........ :-) :-)

To: BulbaMan who wrote (214)	4/20/2012 5:58:51 PM
From: BulbaMan	Read Replies (1) \| Respond to of 513

4/20/12 Contest Update GSK’s hostile takeover bid for HGSI juiced the biotech sector but the broad market, as measured by the Nasdaq Composite Index, was unable to scratch out a gain for the week. At Friday’s close, the Contest median was up 17.44% YTD (vs. up 15.48% YTD a week ago). In comparison, the Nasdaq Biotech Index was up 16.78% YTD (vs. up 13.11% YTD a week ago), while the Nasdaq Composite Index was up 15.17% YTD (vs. up 15.59% YTD a week ago). Remarkably, my own portfolio, up 50.95% YTD, remained in first place, with BIOJIM’s portfolio, up 49.59% YTD, holding on to second place and DON’s portfolio, up 39.59% YTD, still in third place. At Friday's close, 3 of the 38 Contest portfolios were still in the red and 21 of the 38 portfolios were beating the NBI. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week. (Foreign stock prices are not converted to US$ in the weekly and YTD Top 5 & Bottom 5 tables, when posted.) Portfolio adjustments: None. Have a terrific weekend biotechies! (All corrections, especially adjustments for splits, greatly appreciated.) 4/20/12 Rank Name Profit/Loss 1 BULBA 50,945 2 BIOJIM 49,591 3 DONS 39,585 4 BIOMAV 32,414 5 SCARAM 30,957 6 NP1986 30,502 7 BIOFISH 28,824 8 ARTHUR 27,510 9 ROBO 27,336 10 LJM 26,650 Week's Top 5 Gainers Symbol 4/13/12 4/20/12 Wk. %chg. ISR 0.39 0.51 31.54% SQNM 3.99 5.01 25.56% NPC.TO 0.22 0.27 22.73% UBI.AX 0.66 0.80 21.21% BDSI 2.93 3.53 20.48% Week's Top 5 Losers Symbol 4/13/12 4/20/12 Wk. %chg. HALO 11.27 8.07 -28.39% ARNA 2.88 2.17 -24.52% AMRS 3.83 3.02 -21.15% AVII 1.04 0.88 -15.38% ALHYG.PA1.53 1.36 -11.11%